Communicable Diseases

18 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections

Narrower: Gonorrhea 6, Herpes Genitalis 3, Papillomavirus Infections 6, Sexually Transmitted Diseases 16

Treatments and conditions

Communicable Diseases
Treatment and conditionWhere it standsTrials
4CMenB vaccine for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
9vHPV Vaccine for papillomavirus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Circulating Tumor DNA test (ctDNA test) + Dose de-escalation to contralateral neck. + Dose de-escalation to gross disease + Dose de-escalation to gross disease to contralateral neck for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
EGCG and Quinine Sulfate Vaginal Suppository for papillomavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Gepotidacin for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ivermectin for communicable diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Meningococcal Group B Vaccine for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
pBI-11 (1 dose) + Placebo (2 doses) for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
pBI-11 (3 doses) for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RBX2660 for communicable diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Standardized kudzu for sexually transmitted diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) for gonorrheaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml) for gonorrheaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tetanus-Diphtheria booster for papillomavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
UB-621 high-dose for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
UB-621 low-dose for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zoliflodacin for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.